EU medicines regulators look at medtech when forming new strategy
This article was originally published in Clinica
Executive Summary
The European Heads of Medicines Agencies, in framing its 2011-2015 strategy, is considering whether there is a place for medical devices regulation in the European medicines network over the next five years. As things stand, the HMA believes that "there should be closer engagement of the HMA group in considering medical devices strategy".